Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Study to Assess the Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT03817190 is registered in ClinicalTrials.gov with DS Biopharma as lead sponsor.

NCT NCT03817190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Study to Assess the Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
Lead sponsor
DS Biopharma
Phase
Phase 2
Overall status
Terminated
Start date
September 19, 2019
Completion date
September 3, 2020
Enrollment
219 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis